Fuhe Biomedical
FullHope Biomedical Co., Ltd. (FHB) is a Taiwan-based company specializing in innovative research and development of immune system-related services. Founded in 2012, FHB operates internationally with a professional R&D team and certified laboratories compliant with Good Tissue Practice (GTP) and ISO/IEC 17025 standards. The company develops precision diagnostic platforms including immune function analysis and circulating tumor cell analysis, integrating AI to optimize personalized treatment plans. FHB also advances regenerative medicine through proprietary cell therapy technologies such as tumor-specific T cell cultivation and exosome products, validated by clinical trials in collaboration with major medical centers. Their business model includes customized immune diagnostics, cell therapy product development, and contract manufacturing, positioning FHB as a pioneer in precision regenerative medicine with multiple patents and national innovation awards.
Fuhe Biomedical
FullHope Biomedical Co., Ltd. (FHB) is a Taiwan-based company specializing in innovative research and development of immune system-related services. Founded in 2012, FHB operates internationally with a professional R&D team and certified laboratories compliant with Good Tissue Practice (GTP) and ISO/IEC 17025 standards. The company develops precision diagnostic platforms including immune function analysis and circulating tumor cell analysis, integrating AI to optimize personalized treatment plans. FHB also advances regenerative medicine through proprietary cell therapy technologies such as tumor-specific T cell cultivation and exosome products, validated by clinical trials in collaboration with major medical centers. Their business model includes customized immune diagnostics, cell therapy product development, and contract manufacturing, positioning FHB as a pioneer in precision regenerative medicine with multiple patents and national innovation awards.